Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125480172 | 12548017 | 2 | F | 20160504 | 20160727 | 20160712 | 20160801 | EXP | GB-BAUSCH-BL-2016-016319 | BAUSCH AND LOMB | 48.00 | YR | M | Y | 121.00000 | KG | 20160801 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125480172 | 12548017 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | Y | 40069 | 20 | MG | TABLET | |||||||
| 125480172 | 12548017 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | Y | 40069 | TABLET | |||||||||
| 125480172 | 12548017 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | Y | 40069 | 20 | MG | TABLET | |||||||
| 125480172 | 12548017 | 4 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | Y | 0 | 1.3 | MG/M**2 | BIW | |||||||
| 125480172 | 12548017 | 5 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | Y | 0 | 1 | MG/M**2 | BIW | |||||||
| 125480172 | 12548017 | 6 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | Y | 0 | 1 | MG/M**2 | BIW | |||||||
| 125480172 | 12548017 | 7 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Oral | 0 | 800 | MG | BID | ||||||||
| 125480172 | 12548017 | 8 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | 300 | MG | /month | ||||||||
| 125480172 | 12548017 | 9 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Oral | 0 | QD | ||||||||||
| 125480172 | 12548017 | 10 | C | CODEINE | CODEINE | 1 | Oral | 1AS NECESSARY | 0 | ||||||||||
| 125480172 | 12548017 | 11 | C | CODEINE | CODEINE | 1 | Oral | 1AS NECESSARY | 0 | ||||||||||
| 125480172 | 12548017 | 12 | C | LAXIDO | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Oral | 1AS NECESSARY | 0 | ||||||||||
| 125480172 | 12548017 | 13 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 1AS NECESSARY | 0 | 20 | MG | QD | |||||||
| 125480172 | 12548017 | 14 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 1AS NECESSARY | 0 | ||||||||||
| 125480172 | 12548017 | 15 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 1AS NECESSARY | 0 | ||||||||||
| 125480172 | 12548017 | 16 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 0 | 4 | G | QID | ||||||||
| 125480172 | 12548017 | 17 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 0 | 4 | G | QID | ||||||||
| 125480172 | 12548017 | 18 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 0 | 150 | MG | TID | ||||||||
| 125480172 | 12548017 | 19 | C | ZOPICLONE | ZOPICLONE | 1 | Oral | 0 | |||||||||||
| 125480172 | 12548017 | 20 | C | ENOXAPARIN | ENOXAPARIN | 1 | Subcutaneous | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125480172 | 12548017 | 1 | Plasma cell myeloma |
| 125480172 | 12548017 | 4 | Plasma cell myeloma |
| 125480172 | 12548017 | 7 | Antiviral prophylaxis |
| 125480172 | 12548017 | 8 | Prophylaxis |
| 125480172 | 12548017 | 9 | Hypoaesthesia |
| 125480172 | 12548017 | 10 | Back pain |
| 125480172 | 12548017 | 12 | Constipation |
| 125480172 | 12548017 | 13 | Gastrointestinal disorder therapy |
| 125480172 | 12548017 | 14 | Back pain |
| 125480172 | 12548017 | 15 | Pyrexia |
| 125480172 | 12548017 | 18 | Back pain |
| 125480172 | 12548017 | 19 | Insomnia |
| 125480172 | 12548017 | 20 | Thrombosis prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125480172 | 12548017 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125480172 | 12548017 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125480172 | 12548017 | 1 | 20151214 | 0 | ||
| 125480172 | 12548017 | 2 | 20160418 | 20160509 | 0 | |
| 125480172 | 12548017 | 3 | 20160516 | 0 | ||
| 125480172 | 12548017 | 4 | 20151214 | 20160418 | 0 | |
| 125480172 | 12548017 | 5 | 20160418 | 20160509 | 0 | |
| 125480172 | 12548017 | 6 | 20160516 | 0 | ||
| 125480172 | 12548017 | 7 | 20151214 | 0 | ||
| 125480172 | 12548017 | 8 | 20151214 | 0 | ||
| 125480172 | 12548017 | 9 | 20151221 | 0 | ||
| 125480172 | 12548017 | 10 | 2015 | 0 | ||
| 125480172 | 12548017 | 12 | 2015 | 0 | ||
| 125480172 | 12548017 | 13 | 20151214 | 0 | ||
| 125480172 | 12548017 | 14 | 20160504 | 0 | ||
| 125480172 | 12548017 | 18 | 2015 | 0 | ||
| 125480172 | 12548017 | 20 | 201604 | 201604 | 0 |